Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer

ClinicalTrials.gov ID: NCT00789581

Public ClinicalTrials.gov record NCT00789581. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 10:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Study of Doxorubicin/Cyclophosphamide (AC) Followed by Ixabepilone vs. AC Followed by Paclitaxel in Patients With Triple-Negative Early-Stage Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, Phase III, open-label, multicenter study.

Study identification

NCT ID
NCT00789581
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
614 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2008 (Type not available)
Primary completion
Dec 2015 (Actual)
Completion
Nov 2016 (Actual)
Last update posted
Jul 2, 2017

2008 – 2016

United States locations

U.S. sites
69
U.S. states
27
U.S. cities
64
Facility City State ZIP Site status
Northeast Alabama Regional Medical Center Anniston Alabama 36207 —
Cancer Center of Huntsville Huntsville Alabama 35801 —
Clearview Cancer Institute Huntsville Alabama 35805 —
University of Southern Alabama Mobile Alabama 36604 —
Northeast Arkansas Clinic Jonesboro Arkansas 72401 —
Wilshire Oncology Medical Group La Verne California 91750 —
New Hope Cancer and Research Institute Pomona California 91767 —
Eastern Connecticut Hematology Oncology Norwich Connecticut 06360 —
Aventura Medical Center Aventura Florida 33180 —
Lynn Cancer Institute Boca Raton Florida 33428 —
Florida Cancer Care Davie Florida 33328 —
Holy Cross Hospital Fort Lauderdale Florida 33308 —
Florida Cancer Specialists Fort Myers Florida 33901 —
Memorial Regional Cancer Center Hollywood Florida 33021 —
Integrated Community Oncology Network Jacksonville Florida 32256 —
Watson Clinic Center for Cancer Care and Research Lakeland Florida 33805 —
Space Coast Medical Associates Titusville Florida 32796 —
Piedmont Healthcare Atlanta Georgia 30309 —
Emory/Winship Cancer Institute Atlanta Georgia 30322 —
Augusta Oncology Associates Augusta Georgia 30901 —
Medical Oncology Associates of Augusta Augusta Georgia 30901 —
Medical College of Georgia Cancer Specialists Augusta Georgia 30912 —
Northeast Georgia Medical Center Gainesville Georgia 30501 —
Suburban Hem Onc Lawrenceville Georgia 30045 —
Mid-Illinois Hematology & Oncology Normal Illinois 61761 —
Hematology Oncology of the North Shore Skokie Illinois 60076 —
Oncology Hematology Associates of SW Indiana Evansville Indiana 47714 —
Hematology Oncology of Indiana Indianapolis Indiana 46260 —
Providence Medical Group Terre Haute Indiana 47802 —
Kansas City Cancer Centers Overland Park Kansas 66210 —
Cotton O'Neil Cancer Center Topeka Kansas 66606 —
Consultants in Blood Disorders and Cancer Louisville Kentucky 40207 —
Baton Rouge General Medical Center Baton Rouge Louisiana 70806 —
Mercy Hospital Portland Maine 04101 —
Weinberg Cancer Institute at Franklin Square Baltimore Maryland 21237 —
Center for Cancer and Blood Disorders Bethesda Maryland 20817 —
Fallon Clinic Worcester Massachusetts 01608 —
Grand Rapids Clinical Oncology Program Grand Rapids Michigan 49503 —
Fairview Medical Oncology Clinic Edina Minnesota 55436 —
St. Louis Cancer Care Chesterfield Missouri 63017 —
Research Medical Center Kansas City Missouri 64132 —
St. John's Clinic Springfield Missouri 65804 —
Methodist Cancer Center Omaha Nebraska 68114 —
St. Clare's Hospital Oncology and Hematology Denville New Jersey 07834 —
Hematology Oncology Associates of Northern NJ Morristown New Jersey 07960 —
Southern Oncology and Hematology Vineland New Jersey 08360 —
New Mexico Oncology Hematology Consultants Albuquerque New Mexico 87109 —
Alamance Regional Medical Center Burlington North Carolina 27215 —
Oncology Hematology Care Cincinnati Ohio 45242 —
Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center Columbus Ohio 43219 —
Hematology/Oncology Inc Elyria Ohio 44035 —
Hickman Cancer Center (Flower Hospital) Sylvania Ohio 43560 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Bux-Mont Oncology, Fox Chase Cancer Center Rockledge Pennsylvania 18960 —
Medical University of South Carolina Charleston South Carolina 29425 —
South Carolina Oncology Associates, PA Columbia South Carolina 29210 —
Lowcountry Hematology Oncology Mt. Pleasant South Carolina 29464 —
Coastal Cancer Center Myrtle Beach South Carolina 29572 —
Spartanburg Regional Medical Center Spartanburg South Carolina 29303 —
Associates in Hematology Oncology Chattanooga Tennessee 37404 —
Chattanooga Oncology Hematology Associates Chattanooga Tennessee 37404 —
Family Cancer Center Collierville Tennessee 38017 —
Tennessee Oncology, PLLC Nashville Tennessee 37023 —
Coastal Bend Cancer Center Corpus Christi Texas 78463 —
Center for Cancer and Blood Disorders Fort Worth Texas 76104 —
Medical Oncology Methodist Hospital Houston Texas 77030 —
South Texas Oncology and Hematology San Antonio Texas 78258 —
Peninsula Cancer Institute Newport News Virginia 23601 —
Virginia Cancer Institute Richmond Virginia 23235 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00789581, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2017 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00789581 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →